×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Sleeping Bruxism Treatment Market

ID: MRFR/HC/3979-CR
130 Pages
Rahul Gotadki
December 2021

Sleeping Bruxism Treatment Market Research Report Information by Type (Primary Bruxism, Secondary Bruxism), by Treatment (Dental Approaches, Medication), by Cause (Obstructive Sleep Apnea, Gastroesophageal Reflux Disease (GERD), Malocclusion, Sleep Paralysis), by Patient Type (Pediatric, Adult), by End User (Hospitals & Clinics, Dental Clinics) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Sleeping Bruxism Treatment Market Infographic
Purchase Options

Sleeping Bruxism Treatment Market Summary

As per Market Research Future Analysis, the global Sleeping Bruxism Treatment Market is projected to reach USD 1.03 Billion by 2032, growing at a CAGR of 6% from 2023 to 2032. Sleeping bruxism, characterized by jaw clenching and teeth grinding during sleep, leads to symptoms such as tooth wear, neck soreness, and headaches. The market growth is driven by the rising prevalence of sleep bruxism, an increasing child population, and lifestyle changes. However, limited treatment options hinder market expansion. The COVID-19 pandemic has further increased demand due to heightened stress and anxiety levels, leading to more dental consultations. The market presents opportunities in untapped Asia-Pacific regions, where healthcare investments are rising.

Key Market Trends & Highlights

Key trends influencing the Sleeping Bruxism Treatment Market include:

  • Increasing prevalence of sleeping bruxism, with reported cases rising from 7.6% to 13.2% in adolescents.
  • Growing child population, with 3 out of every 10 children affected by sleep bruxism.
  • Rising prevalence of obstructive sleep apnea, affecting 25% of men and 9% of women in Australia.
  • Limited treatment options leading to a focus on preventative measures and multidisciplinary approaches.

Market Size & Forecast

Market Size USD 1.03 Billion by 2032
CAGR 6% (2023-2032)
Largest Regional Market Share Americas

Major Players

Ivoclar Vivadent AG, Ipsen S.A., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Akervall Technologies Inc, Planmeca Oy, Randmark Dental Products, LLC, S4S Limited, Patterson Dental Supply, Inc, Henry Schein, Inc, Pfizer, Inc.

Sleeping Bruxism Treatment Market Trends

Increasing prevalence of sleeping bruxism

Since the past few years, the prevalence of sleeping bruxism has increased. A research article was published in 2017 in the Journal of Oral rehabilitation assessing the Dutch adolescent population. It mentioned the prevalence of 4.2% for awake bruxism and sleep bruxism in the range of 7.6% to 13.2%. In the presence of such trends, the reported cases of headaches and tooth wear due to sleep bruxism are estimated to increase, thereby mounting a negative impact on the patients' lives.

Few effective ways to avoid such complications associated with the disease include administering medications, antidepressants, and muscle relaxants and wearing a mouthguard. Thus, the increasing prevalence of sleeping bruxism is subsequently increasing the demand for the available therapeutic options. Conclusively, it is expected to provide favorable backgrounds for the market to grow during the forecast period.

Growing child population Rising prevalence of obstructive sleep apnea Lifestyle changes Market Restraints

Limited Availability of Treatment Options

Medications are not very effective for treating sleeping bruxism. In such circumstances, it becomes important to manage the consequences of the disorder by the available preventative measures, which involve the application of mandibular advancement devices, occlusal splints, stress management, drugs, occlusal splints, and others. A variety of medications, such as anti-anxiety drugs and muscle relaxants, are significantly employed to treat sleeping bruxism. However, it is reported that such medication options come with the capping of side effects such as constipation, nausea, and muscle weakness, amongst others.

Following the same course, it is evident that bruxism mouthguards ground down with time during bruxism episodes. Thus, it is estimated that the available treatment options are not effective and incorporates side effects, making the patients reluctant to opt for the available treatment options.

Market Opportunities

Untapped Markets in Asia-Pacific

The markets in Asia-Pacific have a relatively low penetration for sleep bruxism products. In recent years, the healthcare sector within the region has witnessed huge investments, thereby expanding the dental industries in developing economies such as India, China, and Australia. The overall Indian healthcare industry has witnessed a rapid change backed by the rising demand for superior quality healthcare products in the country. According to the World Dental Show in 2017, the Indian dental industry was estimated to reach USD 242.81 million at a positive CAGR of 16.0% by the end of 2018.

Sleeping Bruxism Treatment Market Drivers

Market Growth Projections

The Global Sleeping Bruxism Treatment Market Industry is projected to experience substantial growth over the coming years. With an estimated market value of 0.5 USD Billion in 2024, the industry is expected to expand significantly, reaching 1.23 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 8.54% from 2025 to 2035. Factors contributing to this expansion include increasing awareness of bruxism, advancements in treatment technologies, and rising dental care expenditures. The market's trajectory suggests that it will continue to evolve, driven by both consumer demand and innovations in treatment methodologies.

Rising Dental Care Expenditure

An increase in global dental care expenditure is a significant driver for the Global Sleeping Bruxism Treatment Market Industry. As individuals prioritize oral health and invest in preventive care, the demand for bruxism treatments is likely to rise. According to recent data, dental spending is projected to grow, reflecting a broader trend towards health-conscious consumer behavior. This increase in expenditure may lead to higher adoption rates of dental appliances and therapies for bruxism, contributing to the market's anticipated growth. The market is expected to reach 0.5 USD Billion in 2024, with further expansion anticipated as awareness and spending continue to rise.

Increasing Awareness of Bruxism

The rising awareness of bruxism as a prevalent dental disorder is a key driver for the Global Sleeping Bruxism Treatment Market Industry. As more individuals recognize the symptoms and potential consequences of untreated bruxism, the demand for effective treatments is likely to increase. Educational campaigns by dental associations and healthcare providers have contributed to this awareness, leading to a projected market value of 0.5 USD Billion in 2024. This heightened awareness may encourage patients to seek professional help, thereby expanding the market for various treatment options, including dental guards and behavioral therapies.

Integration of Behavioral Therapies

The integration of behavioral therapies into treatment plans for bruxism is emerging as a crucial driver for the Global Sleeping Bruxism Treatment Market Industry. Techniques such as cognitive-behavioral therapy and stress management strategies are being recognized for their effectiveness in reducing bruxism symptoms. This holistic approach not only addresses the physical aspects of bruxism but also its psychological triggers, appealing to a broader patient demographic. As healthcare providers increasingly adopt these therapies, the market is likely to experience growth, with projections indicating a market value of 1.23 USD Billion by 2035, driven by the comprehensive management of bruxism.

Growing Incidence of Stress and Anxiety

The increasing prevalence of stress and anxiety disorders globally is contributing to the rise in bruxism cases, thereby impacting the Global Sleeping Bruxism Treatment Market Industry. Stress is a known trigger for bruxism, and as mental health awareness grows, more individuals are likely to seek treatment for associated symptoms. This correlation suggests that as stress levels rise, so too will the demand for bruxism treatments. Consequently, the market is poised for growth, with estimates indicating a potential market value of 1.23 USD Billion by 2035, driven by the need for effective management strategies for stress-related bruxism.

Technological Advancements in Treatment Options

Technological innovations in dental care are significantly influencing the Global Sleeping Bruxism Treatment Market Industry. The introduction of advanced dental appliances, such as custom-fitted night guards and biofeedback devices, enhances treatment efficacy and patient comfort. These innovations not only improve patient outcomes but also attract more individuals to seek treatment. As the market evolves, the integration of digital health solutions, such as mobile applications for monitoring bruxism, is expected to further drive growth. This trend aligns with the projected market expansion to 1.23 USD Billion by 2035, reflecting a compound annual growth rate of 8.54% from 2025 to 2035.

Market Segment Insights

Sleeping Bruxism Treatment Type Insights

Primary Bruxism

Primary bruxism occurs in the absence of any medical condition. It is associated with social psychological factors, dysfunction of the basal ganglia, tooth interference, and genetic influences. In primary bruxism, chewing muscle activity and the autonomic nervous system is triggered by sleep arousals that eventually lead to teeth grinding.

Secondary Bruxism

Secondary bruxism occurs in the presence of some neurological disorder, medical or psychiatric condition, or due to a side effect of drugs. Sleeping bruxism is highly found in people who consume psychoactive substances. According to the CDC, from 2015 to 2018, around 13.2% of adults used antidepressants; higher use was seen among women, around 17.7% than men, which is around 8.4%. According to the National Institute of Neurological Disorders and Stroke, there are more than 600 neurologic disorders, with approximately 50 million Americans affected each year.

Sleeping Bruxism Treatment Cause Insights

Obstructive Sleep Apnea

According to National Sleep Foundation, one in four people with Obstructive Sleep Apnea (OSA) clench their teeth in sleep. A research article published in the Journal of Clinical Medicine in 2019 carried out a study to understand the relationship between OSA and sleep disorders such as sleeping bruxism. The study concluded that there was a relationship between OSA and Sleep Bruxism (SB) that also depends on the degree of severity of OSA.

Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD) is a digestive disorder that affects the population of every age, from infants to older adults. Sleep bruxism is commonly observed in GERD patients; sleep apnea causes gastric acid to leak into the esophagus, which further triggers micro-arousals, eventually leading to sleep bruxism. A data published in 2018 in PubMed describes the association between GERD and patients with sleep bruxism (SB). Bruxism is strongly associated with GERD patients with frequent bruxism symptoms. Such association between GERD and SB is fueling the market growth of this segment.

Malocclusion

Sleeping Bruxism Treatment Treatment Insights

Dental Approaches

Dental approaches are the first-line treatment given to sleeping bruxism patient and includes splints and mouth guards. Mouth guards help to reduce the pressure on the jaw and teeth whereas occlusal splints are used to prevent primary sleep bruxism. Splints cover the whole maxillary or mandibular dental arch that reduces the masticatory events per hour of sleep. The dental approach also includes dental correction.

Medication

On the basis of its type of medication, the global sleep bruxism market is segmented into muscle relaxants, injections, and anti-anxiety drugs. Muscle relaxant treatment includes injecting the muscle relaxant into the masseter muscle, which weakens the muscle and eventually reduces the grinding of teeth. Treatment with Botulinum Toxin Type A is treatment and relieves the patient from jaw soreness, headaches, and other problems of bruxism. A small amount of injected into the masseter muscle which weakens the muscle and prevents the involuntary grinding of teeth.

Sleeping Bruxism Treatment Patient Type Insights

Americas

The Americas accounted for the largest market share in 2020 in the global sleeping bruxism treatment market, owing to the rising prevalence of sleeping bruxism, rising stress and anxiety among the population

According to the Anxiety & Depression Association of America, anxiety disorders affect about 40 million adults in the US, or 18.1% of the population every year. Moreover, according to the National Institutes of Health, more than 40 million Americans suffer from chronic, long-term sleep disorders, and an additional 20 million report sleeping problems occasionally. Furthermore, the American Sleep Association estimates that sleeping bruxism affects 10% of the adult population and 15% of the children population. Hence, the Americas market is expected to reach USD 318.70 million by 2027 at a CAGR of 6.47% from 2021–2027.

Asia-Pacific

Asia-Pacific is expected to grow rapidly in the sleeping bruxism treatment market owing to the growing adoption of advanced healthcare technology and rising child population

Get more detailed insights about Sleeping Bruxism Treatment Market

Key Companies in the Sleeping Bruxism Treatment Market market include

Industry Developments

  • In January 2021, Henry Schein, Inc. acquired majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies. With this transaction, Henry Schein Medical, the US medical division of Henry Schein, Inc., enters an established and growing multibillion-dollar market for home medical equipment and supplies.
  • In June 2020, Carestream Dental entered into a partnership with Unified Smiles, a management consulting firm based in the US. Under the partnership, Carestream Dental will provide support, guidance, and education to independent practices.

Future Outlook

Sleeping Bruxism Treatment Market Future Outlook

The Global Sleeping Bruxism Treatment Market is projected to grow at an 8.54% CAGR from 2024 to 2035, driven by increasing awareness and innovative treatment options.

New opportunities lie in:

  • Develop advanced oral appliances utilizing smart technology for real-time monitoring.
  • Invest in telehealth platforms to provide remote consultations and treatment plans.
  • Create educational programs targeting dental professionals to enhance bruxism diagnosis and management.

By 2035, the market is expected to demonstrate robust growth, reflecting evolving treatment methodologies and heightened consumer awareness.

Market Segmentation

Sleeping Bruxism Treatment Type Outlook

  • Primary Bruxism
  • Secondary Bruxism

Sleeping Bruxism Treatment Cause Outlook

  • Obstructive Sleep Apnea
  • Gastroesophageal reflux disease (GERD)
  • Malocclusion
  • Sleep Paralysis

Sleeping Bruxism Treatment Region Outlook

  • Americas
  • US
  • Canada
  • South America
  • Europe
  • Western Europe
  • Germany
  • France
  • UK
  • Scandinavia
  • Benelux Union
  • Italy
  • Spain
  • Switzerland
  • Rest of Western Europe
  • Eastern Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East and Africa
  • Middle East
  • Africa

Sleeping Bruxism Treatment End User Outlook

  • Hospitals & Clinics
  • Dental Clinics

Sleeping Bruxism Treatment Treatment Outlook

  • Dental Approaches
  • Mouth Guard
  • NTI-TSS Device
  • Medication
  • Muscle Relaxants
  • Botulinum toxin type A Injections
  • Anti-anxiety Drugs

Sleeping Bruxism Treatment Market Patient Type Outlook

  • Pediatric
  • Adult
  • Male
  • Female

Report Scope

Attribute/Metric Details
  Market Size   2032: USD 1.3 billion
  CAGR   6%
  Base Year   2022
  Forecast Period   2023-2032
  Historical Data   2018 & 2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, Test Type, End User, and Region
  Geographies Covered   Americas, Europe, Asia-Pacific, and Middle East and Africa
  Key Vendors   Ivoclar Vivadent AG (Liechtenstein), Ipsen S.A. (France), Merz Pharma GmbH & Co. KGaA (Germany), Carestream Dental (US), Akervall Technologies Inc (US), Planmeca Oy (Finland), Randmark Dental Products, LLC (US), S4S (UK) Limited (UK), Patterson Dental Supply, Inc (US), Henry Schein, Inc (US), Pfizer, Inc (US), and others
  Key Market Opportunities   • Untapped Markets in Asia-Pacific
  Key Market Drivers   • Increasing prevalence of sleep bruxism • Growing child population • Rising prevalence of obstructive sleep apnea • Lifestyle changes

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

At what CAGR is the sleeping bruxism treatment market projected to grow in the forecast period (2023-2032)?

Sleeping bruxism treatment market projected to grow at approximately 6% CAGR during the assessment period (2023-2032).

How much is the sleeping bruxism treatment market worth in the future?

The valuation of the sleeping bruxism treatment market is estimated to increase to USD 1.03 billion by the end of 2032.

What are the major tailwinds pushing the growth of the sleeping bruxism treatment market?

Increasing prevalence of the disorder and growing funding & healthcare insurance coverage, are major tailwinds pushing the growth of the sleeping bruxism treatment market.

Which region holds the largest share in the sleeping bruxism treatment market?

North America holds the largest share in the sleeping bruxism treatment market, followed by Europe and the Asia Pacific, respectively.

Who are the top players in the sleeping bruxism treatment market?

Ipsen Biopharmaceuticals, Inc., Pfizer Inc., Ivoclar Vivadent AG, Henry Schein, Inc., Merz Pharma GmbH & Co. KGaA, Carestream Dental, Patterson Dental Supply, Inc., S4S Dental Laboratory, Akervall Technologies Inc., PLANMECA OY, and Randmark Dental Products, LLC, are some of the top players operating in the global sleeping bruxism treatment market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions